← Leaderboards
Lars Fredrik Jarskog
University Of North Carolina Chapel Hill
$5,613,556
Attributed
$6,760,596
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $950.8K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,760,596 · 6
By mechanism
R01$3,664,445 · 2
RC1$999,499 · 1
R33$816,233 · 1
K08$802,070 · 1
R21$478,349 · 1
Top collaborators
- Flavio Frohlich5 shared
- Edward E. Smith2 shared
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Renee M. Johnson$6,516,471
- Linda A Dykstra$15,123,867
- Thomas Scott Stroup$20,597,752
- Chris M. McQuiston$1,583,110
Others in their field
Top investigators on “Schizophrenia”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$104,668,216
- Raquel E Gur · University Of Pennsylvania$60,189,770
- Mark J Daly · Broad Institute, Inc.$48,989,393
- John M Kane · Long Island Jewish Medical Center$45,235,871
- Carrie E Bearden · University Of California Los Angeles$42,025,230
- Scott W Woods · Yale University$41,221,536
Research focus
SchizophreniaPharmaceutical PreparationsRandomizedOutpatientsEffectivenessSymptomsAntipsychotic AgentsBasePrimary OutcomeClinical TrialsVulnerable PopulationsSafetyPublic HealthPropertyPublic Health RelevanceDouble-Blind MethodPlacebosDelusionsInterestBiological MarkersBrainAreaAffectAggressive Behavior
Grant awards (21)
3/7 Clozapine for the Prevention of Violence in Schizophrenia: A Randomized Clinical Trial$194,375
R01 · FY2025 · MH · contact PI
3/7 Clozapine for the Prevention of Violence in Schizophrenia: A Randomized Clinical Trial$194,375
R01 · FY2024 · MH · contact PI
3/7 Clozapine for the Prevention of Violence in Schizophrenia: A Randomized Clinical Trial$194,375
R01 · FY2023 · MH · contact PI
3/7 Clozapine for the Prevention of Violence in Schizophrenia: A Randomized Clinical Trial$194,375
R01 · FY2022 · MH · contact PI
3/7 Clozapine for the Prevention of Violence in Schizophrenia: A Randomized Clinical Trial$194,375
R01 · FY2021 · MH · contact PI
Novel pharmacotherapy strategies for obesity in schizophrenia$657,518
R01 · FY2019 · DK · contact PI
Targeting Auditory Hallucinations with Alternating Current Stimulation$293,282
R33 · FY2019 · MH
Novel pharmacotherapy strategies for obesity in schizophrenia$668,723
R01 · FY2018 · DK · contact PI
Targeting Auditory Hallucinations with Alternating Current Stimulation$263,131
R33 · FY2018 · MH
Novel pharmacotherapy strategies for obesity in schizophrenia$668,461
R01 · FY2017 · DK · contact PI
Targeting Auditory Hallucinations with Alternating Current Stimulation$259,820
R33 · FY2017 · MH
Novel pharmacotherapy strategies for obesity in schizophrenia$697,868
R01 · FY2016 · DK · contact PI
Targeting Auditory Hallucinations with Alternating Current Stimulation$225,013
R21 · FY2016 · MH
Targeting Auditory Hallucinations with Alternating Current Stimulation$253,336
R21 · FY2015 · MH
Using fMRI to Measure Negative Symptoms in Schizophrenia$499,499
RC1 · FY2010 · MH
Using fMRI to Measure Negative Symptoms in Schizophrenia$500,000
RC1 · FY2009 · MH
Bcl-2 Family Protein and Apoptosis in Schizophrenia$167,293
K08 · FY2005 · MH
Bcl-2 Family Protein and Apoptosis in Schizophrenia$163,994
K08 · FY2004 · MH
Bcl-2 Family Protein and Apoptosis in Schizophrenia$160,790
K08 · FY2003 · MH
Bcl-2 Family Protein and Apoptosis in Schizophrenia$157,680
K08 · FY2002 · MH
Bcl-2 Family Protein and Apoptosis in Schizophrenia$152,313
K08 · FY2001 · MH